Siraj Ali

Dr. Siraj Ali is a physician-scientist and leads clinical development at EQRx, a Cambridge area biotechnology company. Previously, he led translational research efforts at Foundation Medicine. He focuses on identifying predictive biomarkers for targeted anti-neoplastic and cancer immunotherapies, which encompasses both basic cancer biology and exceptional responders in the clinic. Siraj has co-authored more than 150 peer-reviewed manuscripts, which have accrued 13,000 citations, in journals such as Cancer Discovery, Journal of Clinical Oncology (JCO), The Oncologist, and others. He has given invited and juried presentations at various international conferences. Siraj serves as a reviewer for multiple life-sciences journals and is a member of a NIH study section focused on drug development for oncology.

Siraj earned his B.S. in Biophysics Phi Beta Kappa from Johns Hopkins University and M.D.-Ph.D. program from Harvard Medical School supported by a HHMI fellowship and the Medical Scientists Training Program. He completed residency training at the Beth Israel Deaconess Medical Center/Harvard Medical School in Boston and is board-certified in Anatomic Pathology.